FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032802502> ?p ?o ?g. }

• W3032802502 endingPage "943" @default.
• W3032802502 startingPage "943" @default.
• W3032802502 abstract "An outpatient clinical trial on unresponsive deep-bacterial canine pyoderma (UDCP), without a control group, is presented. The chosen treatment was implemented with a new crystal-solvate of enrofloxacin (enrofloxacin HCl-2H2O or enro-C), in a dual scheme, i.e., 10 mg/kg/day PO, plus its topical administration, prepared as 0.5% in an alginate gel, thrice per day. Fifty-five cases that were unsuccessfully treated previously with another antibacterial drug, were selected and then classified as severe or very severe, according to a clinical score tailored for this trial. Aerobic bacteriological cultures of skin lesions and antibacterial sensitivity tests, were performed. Hematological status, liver, and kidney functions were determined before and after treatment. A complete success was obtained in 32 severe and 23 very severe, cases. The main bacterial isolates were: Staphylococcus intermedius (19/99), Staphylococcus pseudintermedius (16/99), Staphylococcus epidermidis (15/99), Staphylococcus pyogenes (14/99), Staphylococcus saprophyticus, Streptococcus sp., and others including Pseudomonas aeruginosa (6/99). The average duration of treatment was 8.03 days ± 2.1 SD and 12.0 ± 2.4 days, for dogs with severe or very severe UDCP, respectively. The adverse effects caused by enro-C were inconsequential and the hematological tests showed no deviations from normality. The use of enro-C administered dually to treat UDCP, is considered safe and highly effective." @default.
• W3032802502 created "2020-06-05" @default.
• W3032802502 creator A5002867181 @default.
• W3032802502 creator A5017159140 @default.
• W3032802502 creator A5049861170 @default.
• W3032802502 creator A5063020011 @default.
• W3032802502 creator A5073120397 @default.
• W3032802502 date "2020-05-29" @default.
• W3032802502 modified "2023-10-01" @default.
• W3032802502 title "Oral Plus Topical Administration of Enrofloxacin-Hydrochloride-Dihydrate for the Treatment of Unresponsive Canine Pyoderma. A Clinical Trial" @default.
• W3032802502 cites W101706836 @default.
• W3032802502 cites W1676865725 @default.
• W3032802502 cites W1841815590 @default.
• W3032802502 cites W1899417405 @default.
• W3032802502 cites W1906183726 @default.
• W3032802502 cites W1931658698 @default.
• W3032802502 cites W1971684617 @default.
• W3032802502 cites W1985243166 @default.
• W3032802502 cites W1987174837 @default.
• W3032802502 cites W2002479656 @default.
• W3032802502 cites W2013266361 @default.
• W3032802502 cites W2016111769 @default.
• W3032802502 cites W2036114678 @default.
• W3032802502 cites W2040593525 @default.
• W3032802502 cites W204805543 @default.
• W3032802502 cites W2062428619 @default.
• W3032802502 cites W2077592767 @default.
• W3032802502 cites W2078623423 @default.
• W3032802502 cites W2083407602 @default.
• W3032802502 cites W2085023325 @default.
• W3032802502 cites W2106590206 @default.
• W3032802502 cites W2120135710 @default.
• W3032802502 cites W2122628344 @default.
• W3032802502 cites W213015827 @default.
• W3032802502 cites W2132868693 @default.
• W3032802502 cites W2135505775 @default.
• W3032802502 cites W2147532373 @default.
• W3032802502 cites W2159252586 @default.
• W3032802502 cites W2162663302 @default.
• W3032802502 cites W2166257514 @default.
• W3032802502 cites W2175070379 @default.
• W3032802502 cites W2277513779 @default.
• W3032802502 cites W2417286330 @default.
• W3032802502 cites W2895015450 @default.
• W3032802502 cites W2901957329 @default.
• W3032802502 cites W2902052178 @default.
• W3032802502 cites W60580873 @default.
• W3032802502 cites W62526923 @default.
• W3032802502 cites W68924427 @default.
• W3032802502 cites W99462009 @default.
• W3032802502 doi "https://doi.org/10.3390/ani10060943" @default.
• W3032802502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7341524" @default.
• W3032802502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32485942" @default.
• W3032802502 hasPublicationYear "2020" @default.
• W3032802502 type Work @default.
• W3032802502 sameAs 3032802502 @default.
• W3032802502 citedByCount "0" @default.
• W3032802502 crossrefType "journal-article" @default.
• W3032802502 hasAuthorship W3032802502A5002867181 @default.
• W3032802502 hasAuthorship W3032802502A5017159140 @default.
• W3032802502 hasAuthorship W3032802502A5049861170 @default.
• W3032802502 hasAuthorship W3032802502A5063020011 @default.
• W3032802502 hasAuthorship W3032802502A5073120397 @default.
• W3032802502 hasBestOaLocation W30328025021 @default.
• W3032802502 hasConcept C126322002 @default.
• W3032802502 hasConcept C151730666 @default.
• W3032802502 hasConcept C16005928 @default.
• W3032802502 hasConcept C197934379 @default.
• W3032802502 hasConcept C2776580751 @default.
• W3032802502 hasConcept C2777637488 @default.
• W3032802502 hasConcept C2777949923 @default.
• W3032802502 hasConcept C2778512257 @default.
• W3032802502 hasConcept C2778756162 @default.
• W3032802502 hasConcept C2779288629 @default.
• W3032802502 hasConcept C2779489039 @default.
• W3032802502 hasConcept C2779906673 @default.
• W3032802502 hasConcept C2780762169 @default.
• W3032802502 hasConcept C2780820400 @default.
• W3032802502 hasConcept C2780947638 @default.
• W3032802502 hasConcept C501593827 @default.
• W3032802502 hasConcept C523546767 @default.
• W3032802502 hasConcept C54355233 @default.
• W3032802502 hasConcept C71924100 @default.
• W3032802502 hasConcept C86803240 @default.
• W3032802502 hasConcept C89423630 @default.
• W3032802502 hasConcept C90924648 @default.
• W3032802502 hasConceptScore W3032802502C126322002 @default.
• W3032802502 hasConceptScore W3032802502C151730666 @default.
• W3032802502 hasConceptScore W3032802502C16005928 @default.
• W3032802502 hasConceptScore W3032802502C197934379 @default.
• W3032802502 hasConceptScore W3032802502C2776580751 @default.
• W3032802502 hasConceptScore W3032802502C2777637488 @default.
• W3032802502 hasConceptScore W3032802502C2777949923 @default.
• W3032802502 hasConceptScore W3032802502C2778512257 @default.
• W3032802502 hasConceptScore W3032802502C2778756162 @default.
• W3032802502 hasConceptScore W3032802502C2779288629 @default.
• W3032802502 hasConceptScore W3032802502C2779489039 @default.
• W3032802502 hasConceptScore W3032802502C2779906673 @default.

• next